Abstract

BackgroundMayotte, a small island in the Indian Ocean, has been affected for many years by vector-borne diseases. Malaria, Bancroftian filariasis, dengue, chikungunya and Rift Valley fever have circulated or still circulate on the island. They are all transmitted by Culicidae mosquitoes. To limit the impact of these diseases on human health, vector control has been implemented for more than 60 years on Mayotte. In this study, we assessed the resistance levels of four major vector species (Anopheles gambiae, Culex pipiens quinquefasciatus, Aedes aegypti and Aedes albopictus) to two types of insecticides: i) the locally currently-used insecticides (organophosphates, pyrethroids) and ii) alternative molecules that are promising for vector control and come from different insecticide families (bacterial toxins or insect growth regulators). When some resistance was found to one of these insecticides, we characterized the mechanisms involved.MethodsLarval and adult bioassays were used to evaluate the level of resistance. When resistance was found, we tested for the presence of metabolic resistance through detoxifying enzyme activity assays, or for target-site mutations through molecular identification of known resistance alleles.ResultsResistance to currently-used insecticides varied greatly between the four vector species. While no resistance to any insecticides was found in the two Aedes species, bioassays confirmed multiple resistance in Cx. p. quinquefasciatus (temephos: ~ 20 fold and deltamethrin: only 10% mortality after 24 hours). In An. gambiae, resistance was scarce: only a moderate resistance to temephos was found (~5 fold). This resistance appears to be due only to carboxyl-esterase overexpression and not to target modification. Finally, and comfortingly, none of the four species showed resistance to any of the new insecticides.ConclusionsThe low resistance observed in Mayotte’s main disease vectors is particularly interesting, because it leaves a range of tools useable by vector control services. Together with the relative isolation of the island (thus limited immigration of mosquitoes), it provides us with a unique place to implement an integrated vector management plan, including all the good practices learned from previous experiences.

Highlights

  • Mayotte, a small island in the Indian Ocean, has been affected for many years by vector-borne diseases

  • No resistance observed in Ae. aegypti and Ae. albopictus Larval bioassays revealed that colonies from field populations of Ae. aegypti and Ae. albopictus (PT and Kaweni for Ae. albopictus (KWI), respectively) did not show biologically significant resistance to any of the tested larvicides (RR between 0.3 and 1.6, Figure 2 and Additional file 1)

  • The solid red line represents resistant ratios (RR) = 1 and the dotted red line represents RR = 3

Read more

Summary

Introduction

A small island in the Indian Ocean, has been affected for many years by vector-borne diseases. Bancroftian filariasis, dengue, chikungunya and Rift Valley fever have circulated or still circulate on the island. They are all transmitted by Culicidae mosquitoes. While the disease was considered eliminated from the island, some cases of Bancroftian filariasis were recently recorded [8] In addition to these endemic diseases, a major dengue fever outbreak in 1943 [9] and a chikungunya outbreak in 2005 and 2006 have affected Mayotte [10]. Both are due to arboviruses transmitted by Aedes species. New arboviruses recently started to circulate on the island, including the Rift Valley Fever virus [15]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call